New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Chondroitin testing protocol to be published

Chondroitin testing protocol to be published
Article on the most effective testing protocols for chondroitin ingredients was accepted for publication in the peer-reviewed Journal of AOAC International. 

An article on the most effective testing protocols for insuring the purity of chondroitin ingredients, authored by a team of the foremost chondroitin testing experts and scientists, was accepted for publication in the peer-reviewed Journal of AOAC International and will be published in the November/December 2014 issue.

“Electrophoretic Separation of Impurities in Chondroitin Sulfate and Identification of Certain Adulterants that Interfere with the Cetylpyridinium Chloride Titration Assay” was authored by James Neal-Kababick, director of Flora Research Laboratories; Jana Hildreth, director of technology and scientific affairs of Synutra Pure; Synutra’s President Weiguo Zhang; Dr. Gabriel Giancaspro, vice president of foods, dietary supplements and herbal medicines at the United States Pharmacopeia (USP); Dr. Kristie Adams, nuclear magnetic resonance (NMR) spectroscopist at USP; Dr. Joseph Betz, director of the Analytical Methods and Reference Materials Program, Office of Dietary Supplements, National Institutes of Health; and the late Dr. Mark Roman, director of Tampa Bay Analytical Research Laboratories, to whom the research paper is dedicated.  

The most commonly used chondroitin assay method, cetylpyridinium chloride (CPC) titration, can be fooled by various known adulterants. This article illustrates why CPC should be used only after cellulose acetate membrane electrophoresis (CAME) first determines purity. CAME is a complementary methodology to CPC that has been in the USP monograph for chondroitin sulfate for years. An inexpensive, simple, and effective procedure, CAME can effectively deter the practice of adulterating chondroitin ingredients with known adulterants.

Once a paper has been through peer-review and accepted for publication, the Journal offers the option for the paper to be designated “open access,” allowing anyone to access the publication without subscribing to the journal. Because the article contains findings that are critical for protecting the chondroitin sulfate global supply chain, Synutra has sponsored Open Access availability of the article, which is available here.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.